Skip to main content
VCbacked
Log inGet Started

Matisse Pharmaceuticals

Geleen, The Netherlands

Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.

$3.9M raised
Jan 2024
Venture - Series Unknown
BiopharmaBiotechnologyLife Science

Top Investors

Brightlands Venture PartnersChemelot VenturesLimburg Business Development Fund (LBDF)

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Matisse Pharmaceuticals

How much funding has Matisse Pharmaceuticals raised?
Matisse Pharmaceuticals has raised $3.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Who are Matisse Pharmaceuticals's investors?
Matisse Pharmaceuticals's investors include Brightlands Venture Partners, Chemelot Ventures, Limburg Business Development Fund (LBDF).
Where is Matisse Pharmaceuticals headquartered?
Matisse Pharmaceuticals is headquartered in Geleen, The Netherlands.
What does Matisse Pharmaceuticals do?
Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.
What stage is Matisse Pharmaceuticals at?
Matisse Pharmaceuticals is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Matisse Pharmaceuticals — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/matisse-pharmaceuticals. Accessed July 4, 2026.
APA
VCBacked. (2024). Matisse Pharmaceuticals — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/matisse-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Matisse Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/matisse-pharmaceuticals |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M